Moore Capital Management’s Pfizer PFE Stock Holding History

Moore Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-250,000	Closed	-$6.33M	–	636
2025 Q1	$6.33M	Buy	+250,000	New	+$6.54M	0.13%	156
2023 Q4	–	Sell	-102,900	Closed	-$3.41M	–	517
2023 Q3	$3.41M	Buy	+102,900	New	+$3.64M	0.06%	203
2021 Q4	–	Sell	-64,820	Closed	-$2.79M	–	834
2021 Q3	$2.79M	Buy	+64,820	New	+$2.87M	0.04%	382
2015 Q4	–	Sell	-368,900	Closed	-$11M	–	349
2015 Q3	$11M	Buy	+368,900	New	+$11.8M	0.51%	46
2015 Q2	–	Sell	-131,750	Closed	-$4.29M	–	494
2015 Q1	$4.35M	Sell	131,750 -447,950	-77%	-$14.2M	0.1%	181
2014 Q4	$17.1M	Buy	579,700 +527,000	+1,000%	+$15.1M	0.54%	47
2014 Q3	$1.48M	Sell	52,700 -184,574	-78%	-$5.18M	0.03%	301
2014 Q2	$6.68M	Buy	237,274 +25,998	+12%	+$741K	0.16%	145
2014 Q1	$6.44M	Buy	+211,276	New	+$6.3M	0.13%	151
2013 Q4	–	Sell	-18,642	Closed	-$508K	–	427
2013 Q3	$508K	Buy	+18,642	New	+$507K	0.01%	319

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Moore Capital Management's PFE Position: Q2 2025 in Review

Moore Capital Management sold out of Pfizer (PFE) in Q2 2025, closing a stake of 250,000 shares — an estimated $6.33M sold.

Moore Capital Management first reported a position in PFE in Q3 2013 and held it in 10 quarters. The position peaked at $17.1M in Q4 2014. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

Moore Capital Management reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
Moore Capital Management sold 250,000 Pfizer shares in Q2 2025, an estimated $6.33M.
Moore Capital Management first reported a position in Pfizer in Q3 2013 and held it in 10 quarters.
Moore Capital Management's Pfizer position peaked at $17.1M in Q4 2014.
2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Moore Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.